Membrane proteomics of cellular responses to β-blocker carvedilol
Carvedilol is a third generation β-blocker of multifaceted therapeutic potential. It is a non-selective antagonist of β1 and, β2 adrenoceptors and exhibits anti-α1–adrenergic activity. Clinically, carvedilol has been used in the treatment of congestive heart failure, ischemic heart disease and hyper...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/38936 |